Jan 20, 2011 - Dr. Reddy's Laboratories today announced that it has launched Pantoprazole Sodium Delayed-Released tablets (20mg and 40mg strengths), a bioequivalent generic version of Protonix® Tablets in the US market. The Food & Drug Administration (FDA) approved Dr. Reddy's ANDA for Pantoprazole Sodium Delayed-Released tablets on January 19, 2011.
Along with Dr. Reddy's, Mylan, Kudco, torrent and on other player got final approval for Pantoprazole DR tablets. This final approval is due to the expiry of product patent in US. Earlier, Sun pharma and Teva was having final approval for the product.
Pantoprazole Sodium Delayed-Released tablets had total U.S. sales of approximately $1.8 billion for the twelve months ending September 30, 2010 according to IMS Health. Both strengths of Dr. Reddy's Pantoprazole Sodium Delayed-Released tablets are available in 90 count bottles.
No comments:
Post a Comment